National expert consensus on short-acting beta₂-agonist overreliance in asthma care in Malaysia

References

• Nwaru BI, Ekström M, Hasvold P, Wiklund F, Telg G, Janson C. Overuse of short-acting β(2)-agonists in asthma is associated with increased risk of exacerbation and mortality: a nationwide cohort study of the global SABINA programme. Eur Respir J. 2020;55(4):1901872. doi:10.1183/13993003.01872-2019.
   PubMed Web of Science ®Google Scholar
• Wang CY, Lai CC, Wang YH, Wang HC. The prevalence and outcome of short-acting β2-agonists overuse in asthma patients in Taiwan. NPJ Prim Care Respir Med. 2021;31(1):19. doi:10.1038/s41533-021-00231-1.
   PubMed Web of Science ®Google Scholar
• FitzGerald JM, Tavakoli H, Lynd LD, Al Efraij K, Sadatsafavi M. The impact of inappropriate use of short acting beta agonists in asthma. Respir Med. 2017;131:135–140. doi:10.1016/j.rmed.2017.08.014.
   PubMed Web of Science ®Google Scholar
• Global Initiative for Asthma - GINA. Global strategy for asthma management and prevention (2019 update) [assessed 15 May 2024]. https://ginasthma.org/wp-content/uploads/2019/06/GINA-2019-main-report-June-2019-wms.pdf.
   Google Scholar
• Ban AY-L, Vengadasalam P, Taher SW, Mohd Zim MA, Sirol Aflah SS, Daut UN, Hyder Ali IA, Pereirasamy L, Omar A, Ibrahim A, et al. Short-acting β(2)-agonist prescription patterns and clinical outcomes in Malaysia: a nationwide cohort of the SABINA III study. Malays Fam Physician. 2023;18:32. doi:10.51866/oa.258.
   PubMedGoogle Scholar
• Wang HC, Djajalaksana S, Sharma L, Theerakittikul T, Lim HF, Yoo KH, et al. Evaluation of short-acting Beta-2-agonist prescriptions and associated clinical outcomes: findings from the SABA use IN Asthma (SABINA) study in Asia. World Allergy Organ J. 2023;16(10):100823.
   PubMed Web of Science ®Google Scholar
• Slejko JF, Ghushchyan VH, Sucher B, Globe DR, Lin S-L, Globe G, Sullivan PW. Asthma control in the United States, 2008–2010: indicators of poor asthma control. J Allergy Clin Immunol. 2014;133(6):1579–1587. doi:10.1016/j.jaci.2013.10.028.
   PubMed Web of Science ®Google Scholar
• den Akker IL, Werkhoven A, Verheij T. Over-prescription of short-acting beta agonists in the treatment of asthma. Fam Pract. 2021;38(5):612–616. doi:10.1093/fampra/cmab013.
   PubMed Web of Science ®Google Scholar
• Azzi EA, Kritikos V, Peters MJ, Price DB, Srour P, Cvetkovski B, Bosnic-Anticevich S. Understanding reliever overuse in patients purchasing over-the-counter short-acting beta(2) agonists: an Australian community pharmacy-based survey. BMJ Open. 2019;9(8):e028995. doi:10.1136/bmjopen-2019-028995.
   PubMed Web of Science ®Google Scholar
• Department of Statistics Malaysia. Malaysia at a glance [assessed 3 April 2024. https://open.dosm.gov.my/.
   Google Scholar
• Ministry of Health Malaysia. National Health and Morbidity Survey 2011. Volume III: healthcare demand and out-of-pocket health expenditure [assessed 15 May 2024] https://iku.moh.gov.my/images/IKU/Document/REPORT/NHMS2011-VolumeIII.pdf.
   Google Scholar
• Thomas S, Beh L, Nordin RB. Health care delivery in Malaysia: changes, challenges and champions. J Public Health Afr. 2011;2(2):e23. doi:10.4081/jphia.2011.e23.
   PubMedGoogle Scholar
• Ministry of Health Malaysia. National Health and Morbidity Survey 2019. Non-communicable diseases, healthcare demand, and health literacy: key findings. [assessed 15 May 2024] https://iku.gov.my/images/IKU/Document/REPORT/NHMS2019/Infographic_Booklet_NHMS_2019-English.pdf.
   Google Scholar
• Bateman ED, Price DB, Wang H-C, Khattab A, Schonffeldt P, Catanzariti A, van der Valk RJP, Beekman MJHI. Short-acting β(2)-agonist prescriptions are associated with poor clinical outcomes of asthma: the multi-country, cross-sectional SABINA III study. Eur Respir J. 2022;59(5):2101402. doi:10.1183/13993003.01402-2021.
   PubMed Web of Science ®Google Scholar
• Chin MC, Sivasampu S, Khoo EM. Prescription of oral short-acting beta 2-agonist for asthma in non-resource poor settings: a national study in Malaysia. PLOS One. 2017;12(6):e0180443. doi:10.1371/journal.pone.0180443.
   PubMed Web of Science ®Google Scholar
• Poh ME, Ampikaipakan S, Liam CK, Chai CS, Ramanaidoo D, Haja Mydin H. Management of asthma exacerbations in Southeast Asian tertiary care. J Asthma Allergy. 2021;14:629–640. doi:10.2147/JAA.S309143.
   PubMed Web of Science ®Google Scholar
• Fink A, Kosecoff J, Chassin M, Brook RH. Consensus methods: characteristics and guidelines for use. Am J Public Health. 1984;74(9):979–983. doi:10.2105/ajph.74.9.979.
   PubMed Web of Science ®Google Scholar
• Broder MS, Gibbs SN, Yermilov I. An adaptation of the RAND/UCLA modified Delphi panel method in the time of COVID-19. J Healthc Leadersh. 2022;14:63–70.
   PubMed Web of Science ®Google Scholar
• Global Initiative for Asthma - GINA. Global strategy for asthma management and prevention 2024. update) [assessed 15 May 2024]. https://ginasthma.org/wp-content/uploads/2024/05/GINA-2024-Main-Report-WMS-1.pdf.
   Google Scholar
• Ministry of Health Malaysia. Malaysian CPG for Management of Asthma in Adult 2017 assessed 26 September 2024. https://www.moh.gov.my/moh/resources/Penerbitan/CPG/Respiratory/CPG%20Management%20of%20Asthma%20in%20Adults.pdf.
   Google Scholar
• Asthma Respiratory Foundation NZ. New Zealand adolescent & adult asthma guidelines 2020. [assessed 26 September 2023]. https://www.nzrespiratoryguidelines.co.nz/uploads/8/3/0/1/83014052/arfnz_adolescent_and_adult_asthma_guidelines_.pdf.
   Google Scholar
• National Asthma Council Australia. Australian asthma handbook assessed 26 September 2023. https://www.asthmahandbook.org.au/acute-asthma/clinical/post-acute-care.
   Google Scholar
• International Primary Care Respiratory Group. Asthma right care case study [assessed 27 September 2023. https://www.ipcrg.org/sites/ipcrg/files/content/attachments/2021-09-13/SABA%20OTC%20Case%20Study%20-%20FINAL.pdf.
   Google Scholar
• The Swedish National Airway Register assessed 28 September 2023. https://lvr.registercentrum.se/in-english/the-swedish-national-airway-register/p/HJAjrgGPD.
   Google Scholar
• NIHR Global Health Research Unit on Respiratory Health (RESPIRE) UoE. What is RESPIRE? assessed 28 September 2023. https://www.ed.ac.uk/usher/respire/about/what-is-respire.
   Google Scholar
• Ministry of Health Malaysia. National Health & Morbidity Survey 2023. [accessed 28 September 2023]. Available from: https://iku.gov.my/nhms-2023.
   Google Scholar
• Ministry of Health Malaysia. Respiratory medication therapy adherence clinic protocol—asthma/COPD (adult & pediatric), 2nd edition [accessed 2 October 2023. https://www.pharmacy.gov.my/v2/sites/default/files/document-upload/book.-protocol-respiratory-2.6-ver2_0.pdf.
   Google Scholar
• British Thoracic Society. BTS/SIGN Guideline for the management of asthma 2019 [accessed 3 October 2023]. https://www.brit-thoracic.org.uk/document-library/guidelines/asthma/bts-sign-guideline-for-the-management-of-asthma-2019/.
   Google Scholar
• International Primary Care Respiratory Group. Reliever Reliance Test - English [accessed 2 November 2023. https://www.ipcrg.org/resources/search-resources/reliever-reliance-test-english.
   Google Scholar
• Mohd Isa NA, Cheng CL, Nasir NH, Naidu V, Gopal VR, Alexander AK. Asthma control and asthma treatment adherence in primary care: results from the prospective, multicentre, non-interventional, observational cohort ASCOPE study in Malaysia. Med J Malaysia. 2020;75(4):331–337.
   PubMedGoogle Scholar
• Hussein N, Ramli R, Ishak I, Ho BK, Mohamad Isa S, Aman Z, Nordin A, Tan SF, Harun H, Liew SM, et al. Assessment of asthma control and associated risk factors: findings from the Klang Asthma Cohort Study in Malaysia. Eur Respir J. 2021;58(suppl 65):PA1001. doi:10.1183/13993003.congress-2021.PA1001.
   Google Scholar
• Loh ZC, Hussain R, Balan S, Saini B, Muneswarao J, Ong SC, Babar Z-U-D. Perceptions, attitudes, and behaviors of asthma patients towards the use of short-acting β2-agonists: a systematic review. PLOS One. 2023;18(4):e0283876. doi:10.1371/journal.pone.0283876.
   PubMed Web of Science ®Google Scholar
• Blakeston S, Harper G, Zabala Mancebo J. Identifying the drivers of patients’ reliance on short-acting β2-agonists in asthma. J Asthma. 2021;58(8):1094–1101. doi:10.1080/02770903.2020.1761382.
   PubMed Web of Science ®Google Scholar
• Chan AHY, Katzer CB, Horne R, Haughney J, Correia de Sousa J, Williams S, et al. SABA Reliance Questionnaire (SRQ): identifying patient beliefs underpinning reliever overreliance in asthma. J Allergy Clin Immunol Pract. 2020;8(10):3482–3489.
   PubMed Web of Science ®Google Scholar
• Ellis AK, Foran V, Kaplan A, Mitchell PD. Clarifying SABA overuse: translating Canadian Thoracic Society guidelines into clinical practice. Allergy Asthma Clin Immunol. 2022;18(1):48. doi:10.1186/s13223-022-00690-2.
   PubMed Web of Science ®Google Scholar
• Crowther L, Pearson M, Cummings H, Crooks MG. Towards codesign in respiratory care: development of an implementation-ready intervention to improve guideline-adherent adult asthma care across primary and secondary care settings (The SENTINEL Project). BMJ Open Respir Res. 2022;9(1):e001155. doi:10.1136/bmjresp-2021-001155.
   PubMed Web of Science ®Google Scholar
• Crooks MG, Crowther L, Cummings H, Cohen J, Huang C, Pitel L, Pearson M, Morice A, Turgoose J, Faruqi S, et al. Improving asthma care through implementation of the SENTINEL programme: findings from the pilot site. ERJ Open Res. 2023;9(3):00685–2022. doi:10.1183/23120541.00685-2022.
   PubMedGoogle Scholar
• Albertson TE, Sutter ME, Chan AL. The acute management of asthma. Clin Rev Allergy Immunol. 2015;48(1):114–125. doi:10.1007/s12016-014-8448-5.
   PubMed Web of Science ®Google Scholar
• Emirates Thoracic Society. Algorithm for the management of adult asthma in the emergency department. 2021.
   Google Scholar
• IQVIA IMS. SABA inhalers and tablets dispensed in Malaysia. 2019.
   Google Scholar
• Gibson P, Henry D, Francis L, Cruickshank D, Dupen F, Higginbotham N, Henry R, Sutherland D. Association between availability of non-prescription b2 agonist inhalers and undertreatment of asthma. BMJ. 1993;306(6891):1514–1518. doi:10.1136/bmj.306.6891.1514.
   PubMed Web of Science ®Google Scholar
• Loh ZC, Hussain R, Ong SC, Saini B, Muneswarao J, Ur-Rehman A, et al. Over-the-counter use of short-acting beta-2 agonists: a systematic review. J Pharm Policy Pract. 2023;16(1):119.
   PubMed Web of Science ®Google Scholar
• Kaplan AG, Correia-de-Sousa J, McIvor A, Global Policy Steering Group on Improving Asthma Outcomes Global quality statements on reliever use in asthma in adults and children older than 5 years of age. Adv Ther. 2021;38(3):1382–1396. doi:10.1007/s12325-021-01621-0.
   PubMed Web of Science ®Google Scholar
• Drug Topics. OTC update: asthma medications [accessed 27 September 2023. https://www.drugtopics.com/view/otc-update-asthma-medications.
   Google Scholar
• Lee H, Ryu J, Chung SJ, Yeo Y, Park TS, Park DW, Moon J-Y, Kim T-H, Sohn JW, Yoon HJ, et al. Short-acting beta2-agonist use in asthma in Korea: a 10-Year population-based study. Allergy Asthma Immunol Res. 2021;13(6):945–953. doi:10.4168/aair.2021.13.6.945.
   PubMed Web of Science ®Google Scholar
• Crossingham I, Turner S, Ramakrishnan S, Fries A, Gowell M, Yasmin F, et al. Combination fixed-dose beta agonist and steroid inhaler as required for adults or children with mild asthma. Cochrane Database Syst Rev. 2021;5(5):Cd013518.
   PubMedGoogle Scholar
• Sobieraj DM, Weeda ER, Nguyen E, Coleman CI, White CM, Lazarus SC, Blake KV, Lang JE, Baker WL. Association of inhaled corticosteroids and long-acting β-agonists as controller and quick relief therapy with exacerbations and symptom control in persistent asthma: a systematic review and meta-analysis. JAMA. 2018;319(14):1485–1496. doi:10.1001/jama.2018.2769.
   PubMed Web of Science ®Google Scholar
• Beasley R, Harrison T, Peterson S, Gustafson P, Hamblin A, Bengtsson T, Fagerås M. Evaluation of budesonide-formoterol for maintenance and reliever therapy among patients with poorly controlled asthma: a systematic review and meta-analysis. JAMA Netw Open. 2022;5(3):e220615. doi:10.1001/jamanetworkopen.2022.0615.
   PubMed Web of Science ®Google Scholar
• Patel M, Pilcher J, Hancox RJ, Sheahan D, Pritchard A, Braithwaite I, et al. The use of β2-agonist therapy before hospital attendance for severe asthma exacerbations: a post-hoc analysis. NPJ Prim Care Respir Med. 2015;25:14099.
   PubMed Web of Science ®Google Scholar
• Tattersfield AE, Postma DS, Barnes PJ, Svensson K, Bauer CA, O’Byrne PM, Löfdahl CG, Pauwels RA, Ullman A. Exacerbations of asthma: a descriptive study of 425 severe exacerbations. The FACET International Study Group. Am J Respir Crit Care Med. 1999;160(2):594–599. doi:10.1164/ajrccm.160.2.9811100.
   PubMed Web of Science ®Google Scholar
• Dhruve H, d’Ancona G, Nanzer-Kelly A, Jackson DJ. Adherence to inhaled corticosteroids (ICS) according to demographic characteristics in asthma (Abstract P115). Thorax. 2021;76: a 1–A256.
   Web of Science ®Google Scholar
• Wang J, Zhai C, Wang Q, Shi W, Fang W, Yan X, Zhang Q, Xie X, Li S, Li M, et al. Determinants of ICS therapy adherence in patients with asthma. Am J Manag Care. 2021;27(2):e36–e41. doi:10.37765/ajmc.2021.88587.
   PubMed Web of Science ®Google Scholar
• Teng SY, Yusoff AM, Foong SY, Aziz H, Mohamad Pakarul Razy NH, Hashim NI, et al. A cross sectional study on adult asthma patients’ adherence to inhaled corticosteroids (ICS) in Hospital Putrajaya (P55). Med J Malaysia. 2021;76:33.
   Google Scholar
• Nannini LJ, Neumayer NS, Brandan N, Fernández OM, Flores DM. Asthma-related hospitalizations after implementing SABA-free asthma management with a maintenance and anti-inflammatory reliever regimen. Eur Clin Respir J. 2022;9(1):2110706. doi:10.1080/20018525.2022.2110706.
   PubMed Web of Science ®Google Scholar
• Kponee-Shovein K, Marvel J, Ishikawa R, Choubey A, Kaur H, Thokala P, et al. Carbon footprint and associated costs of asthma exacerbation care among UK adults. J Med Econ. 2022;25(1):524–531.
   PubMed Web of Science ®Google Scholar
• Levy ML, Bateman ED, Allan K, Bacharier LB, Bonini M, Boulet LP, et al. Global access and patient safety in the transition to environmentally friendly respiratory inhalers: the Global Initiative for Asthma perspective. Lancet. 2023;402(10406):1012–1016.
   PubMed Web of Science ®Google Scholar
• Kocks JWH, Chrystyn H, van der Palen J, Thomas M, Yates L, Landis SH, et al. Systematic review of association between critical errors in inhalation and health outcomes in asthma and COPD. NPJ Prim Care Respir Med. 2018;28(1):43.
   PubMed Web of Science ®Google Scholar
• Price DB, Román-Rodríguez M, McQueen RB, Bosnic-Anticevich S, Carter V, Gruffydd-Jones K, et al. Inhaler errors in the CRITIKAL Study: type, frequency, and association with asthma outcomes. J Allergy Clin Immunol Pract. 2017;5(4):1071–1081.
   PubMed Web of Science ®Google Scholar
• Roche N, Aggarwal B, Boucot I, Mittal L, Martin A, Chrystyn H. The impact of inhaler technique on clinical outcomes in adolescents and adults with asthma: a systematic review. Respir Med. 2022;202:106949. doi:10.1016/j.rmed.2022.106949.
   PubMed Web of Science ®Google Scholar
• Klijn SL, Hiligsmann M, Evers S, Román-Rodríguez M, van der Molen T, van Boven JFM. Effectiveness and success factors of educational inhaler technique interventions in asthma & COPD patients: a systematic review. NPJ Prim Care Respir Med. 2017;27(1):24. doi:10.1038/s41533-017-0022-1.
   PubMed Web of Science ®Google Scholar
• Jia X, Zhou S, Luo D, Zhao X, Zhou Y, Cui YM. Effect of pharmacist-led interventions on medication adherence and inhalation technique in adult patients with asthma or COPD: a systematic review and meta-analysis. J Clin Pharm Ther. 2020;45(5):904–917. doi:10.1111/jcpt.13126.
   PubMed Web of Science ®Google Scholar
• Engelkes M, Janssens HM, de Jongste JC, Sturkenboom MC, Verhamme KM. Medication adherence and the risk of severe asthma exacerbations: a systematic review. Eur Respir J. 2015;45(2):396–407. doi:10.1183/09031936.00075614.
   PubMed Web of Science ®Google Scholar
• Plaza V, Fernández-Rodríguez C, Melero C, Cosío BG, Entrenas LM, de Llano LP, et al. Validation of the ‘test of the adherence to inhalers’ (TAI) for asthma and COPD Patients. J Aerosol Med Pulm Drug Deliv. 2016;29(2):142–152.
   PubMed Web of Science ®Google Scholar
• Muneswarao J, Hassali MA, Ibrahim B, Saini B, Naqvi AA, Hyder Ali IA, et al. Translation and validation of the test of adherence to inhalers (TAI) questionnaire among adult patients with asthma in Malaysia. J Asthma. 2021;58(9):1229–1236.
   PubMed Web of Science ®Google Scholar
• Pinnock H, Parke HL, Panagioti M, Daines L, Pearce G, Epiphaniou E, Bower P, Sheikh A, Griffiths CJ, Taylor SJC, et al. Systematic meta-review of supported self-management for asthma: a healthcare perspective. BMC Med. 2017;15(1):64. doi:10.1186/s12916-017-0823-7.
   PubMed Web of Science ®Google Scholar
• Hodkinson A, Bower P, Grigoroglou C, Zghebi SS, Pinnock H, Kontopantelis E, Panagioti M. Self-management interventions to reduce healthcare use and improve quality of life among patients with asthma: systematic review and network meta-analysis. BMJ. 2020;370:m2521. doi:10.1136/bmj.m2521.
   PubMed Web of Science ®Google Scholar
• Vogelmeier C, Naya I, Ekelund J. Budesonide/formoterol maintenance and reliever therapy in Asian patients (aged ≥16 years) with asthma: a sub-analysis of the COSMOS study. Clin Drug Investig. 2012;32(7):439–449. doi:10.2165/11598840-000000000-00000.
   PubMed Web of Science ®Google Scholar
• Beasley R, Holliday M, Reddel HK, Braithwaite I, Ebmeier S, Hancox RJ, Harrison T, Houghton C, Oldfield K, Papi A, et al. Controlled trial of budesonide-formoterol as needed for mild asthma. N Engl J Med. 2019;380(21):2020–2030. doi:10.1056/NEJMoa1901963.
   PubMed Web of Science ®Google Scholar
• O’Byrne PM, FitzGerald JM, Bateman ED, Barnes PJ, Zhong N, Keen C, Jorup C, Lamarca R, Ivanov S, Reddel HK, et al. Inhaled combined budesonide-formoterol as needed in mild asthma. N Engl J Med. 2018;378(20):1865–1876. doi:10.1056/NEJMoa1715274.
   PubMed Web of Science ®Google Scholar
• Bateman ED, Reddel HK, O’Byrne PM, Barnes PJ, Zhong N, Keen C, Jorup C, Lamarca R, Siwek-Posluszna A, FitzGerald JM, et al. As-needed budesonide-formoterol versus maintenance budesonide in mild asthma. N Engl J Med. 2018;378(20):1877–1887. doi:10.1056/NEJMoa1715275.
   PubMed Web of Science ®Google Scholar
• Hussein N, Liew SM, Hanafi NS, Lee PY, Cheong AT, Ghazali SS, et al. Asthma control and care among six public health clinic attenders in Malaysia: a cross-sectional study. Health Sci Rep. 2023;6(5):e1021.
   PubMedGoogle Scholar
• Bridgeman MB, Wilken LA. Essential role of pharmacists in asthma care and management. J Pharm Pract. 2021;34(1):149–162. doi:10.1177/0897190020927274.
   PubMed Web of Science ®Google Scholar
• Yong YV, Shafie AA. Using a dynamic adherence Markov model to assess the efficiency of respiratory medication therapy adherence clinic (RMTAC) on asthma patients in Malaysia. Cost Eff Resour Alloc. 2018;16(1):36. doi:10.1186/s12962-018-0156-1.
   PubMedGoogle Scholar
• Chiew SY, Ghazali NH, Choon CJ, Chang PN, Lee MY, Yap LS, et al. Cost-effectiveness of pharmacist-managed respiratory medication therapy adherence clinic (RMTAC) on asthma patients: a prospective multicentre study. Pharm Res Rep. 2022;5(2):18–27.
   Google Scholar
• García-Cárdenas V, Sabater-Hernández D, Kenny P, Martínez-Martínez F, Faus MJ, Benrimoj SI. Effect of a pharmacist intervention on asthma control. A cluster randomised trial. Respir Med. 2013;107(9):1346–1355. doi:10.1016/j.rmed.2013.05.014.
   PubMed Web of Science ®Google Scholar
• Mehuys E, Van Bortel L, De Bolle L, Van Tongelen I, Annemans L, Remon JP, et al. Effectiveness of pharmacist intervention for asthma control improvement. Eur Respir J. 2008;31(4):790–799.
   PubMed Web of Science ®Google Scholar
• Wong MD, Manley RT, Stettin G, Chen W, Salmun LM. Intervention to reduce unnecessary dispensing of short-acting beta-agonists in patients with asthma. Ann Pharmacother. 2010;44(4):623–629. doi:10.1345/aph.1M697.
   PubMed Web of Science ®Google Scholar
• Meghji J, Mortimer K, Agusti A, Allwood BW, Asher I, Bateman ED, et al. Improving lung health in low-income and middle-income countries: from challenges to solutions. Lancet. 2021;397(10277):928–940.
   PubMed Web of Science ®Google Scholar
• Williams S, Sheikh A, Campbell H, Fitch N, Griffiths C, Heyderman RS, et al. Respiratory research funding is inadequate, inequitable, and a missed opportunity. Lancet Respir Med. 2020;8(8):e67–e68.
   PubMed Web of Science ®Google Scholar
• Levy ML. The national review of asthma deaths: what did we learn and what needs to change? Breathe . 2015;11(1):14–24. doi:10.1183/20734735.008914.
   Web of Science ®Google Scholar
• Hussein N, Ramli R, Liew SM, Hanafi NS, Lee PY, Cheong AT, Sazlina S-G, Mohd Ahad A, Patel J, Schwarze J, et al. Healthcare resources, organisational support and practice in asthma in six public health clinics in Malaysia. NPJ Prim Care Respir Med. 2023;33(1):13. doi:10.1038/s41533-023-00337-8.
   PubMed Web of Science ®Google Scholar